Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.18 USD -4.21% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supernus Pharmaceuticals Inc
Total Equity Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Total Equity
$1B
CAGR 3-Years
8%
CAGR 5-Years
13%
CAGR 10-Years
40%
Johnson & Johnson
NYSE:JNJ
Total Equity
$70.2B
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Bristol-Myers Squibb Co
NYSE:BMY
Total Equity
$17.1B
CAGR 3-Years
-23%
CAGR 5-Years
-1%
CAGR 10-Years
1%
Pfizer Inc
NYSE:PFE
Total Equity
$87.7B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
1%
Merck & Co Inc
NYSE:MRK
Total Equity
$44.5B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
0%
Eli Lilly and Co
NYSE:LLY
Total Equity
$14.2B
CAGR 3-Years
22%
CAGR 5-Years
33%
CAGR 10-Years
-2%

See Also

What is Supernus Pharmaceuticals Inc's Total Equity?
Total Equity
1B USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Total Equity amounts to 1B USD.

What is Supernus Pharmaceuticals Inc's Total Equity growth rate?
Total Equity CAGR 10Y
40%

Over the last year, the Total Equity growth was 10%. The average annual Total Equity growth rates for Supernus Pharmaceuticals Inc have been 8% over the past three years , 13% over the past five years , and 40% over the past ten years .

Back to Top